Effect of Intranasal Administration of CV-11974, a Type 1 Angiotensin II Receptor Antagonist, on Airway Hyperresponsiveness and Airway Inflammation Induced by Antigen Inhalation in Guinea Pigs

2002 ◽  
Vol 129 (1) ◽  
pp. 86-92 ◽  
Author(s):  
Shigeharu Myou ◽  
Masaki Fujimura ◽  
Toshiyuki Kita ◽  
Kazuyoshi Watanabe ◽  
Tatsuki Hirose ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Airway Inflammation ◽  
Guinea Pigs ◽  
Airway Hyperresponsiveness ◽  
Intranasal Administration ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonist

Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases

Cardiology ◽  
2002 ◽  
Vol 97 (2) ◽  
pp. 111-112 ◽  
Author(s):  
Masahiro Ogawa ◽  
Nobuyuki Hirose ◽  
Masaro Ogimoto ◽  
Hiroaki Matsuki ◽  
Koichiro Miki ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Pulmonary Diseases ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonist ◽  
Beneficial Effects

scholarly journals Type 1 angiotensin II receptor antagonists in cardiovascular diseases: Valsartan

2011 ◽  
Vol 17 (4) ◽  
pp. 325-332 ◽  
Author(s):  
Y. V. Sviryaev ◽  
N. E. Zvartau
Keyword(s):  
Angiotensin Ii ◽  
Cardiovascular Diseases ◽  
Receptor Antagonist ◽  
Antihypertensive Effect ◽  
Clinical Use ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Angiotensin Ii Receptor Antagonist ◽  
Receptor Antagonists

The article focuses on antihypertensive effect, organoprotection properties and clinical use of angiotensin II receptor antagonist valsartan in patients with cardiovascular diseases.

Sign in / Sign up

Export Citation Format

Share Document